Clinical Trials
4
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (100.0%)SteadiSet™ Pilot Study (SteP Study)
Not Applicable
Terminated
- Conditions
- Type 1 Diabetes MellitusIDDMDiabetes Mellitus, Insulin-Dependent, 1Diabetes Mellitus, Type IType 1 Diabetes
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- Capillary Biomedical, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT04591925
- Locations
- 🇦🇹
Medizinische Universität Graz, Graz, Austria
"FEXIS": (Feasibility of an Extended Wear CSII Set in Participants With T1DM)
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 1Type 1 Diabetes MellitusDiabetes Mellitus, Insulin-Dependent, 1Type 1 Diabetes
- First Posted Date
- 2020-08-07
- Last Posted Date
- 2023-03-07
- Lead Sponsor
- Capillary Biomedical, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04503564
- Locations
- 🇦🇺
St Vincent's Hospital (Melbourne) Ltd - Fitzroy, Melbourne, Australia
Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients ("PEXIS")
Not Applicable
Completed
- Conditions
- Type 1 DiabetesDiabetes Mellitus, Type 1
- First Posted Date
- 2020-05-21
- Last Posted Date
- 2022-08-11
- Lead Sponsor
- Capillary Biomedical, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT04398030
- Locations
- 🇺🇸
AMCR Institute, Escondido, California, United States
News
No news found